Markowitsch, S.D.; Vakhrusheva, O.; Schupp, P.; Akele, Y.; Kitanovic, J.; Slade, K.S.; Efferth, T.; Thomas, A.; Tsaur, I.; Mager, R.;
et al. Shikonin Inhibits Cell Growth of Sunitinib-Resistant Renal Cell Carcinoma by Activating the Necrosome Complex and Inhibiting the AKT/mTOR Signaling Pathway. Cancers 2022, 14, 1114.
https://doi.org/10.3390/cancers14051114
AMA Style
Markowitsch SD, Vakhrusheva O, Schupp P, Akele Y, Kitanovic J, Slade KS, Efferth T, Thomas A, Tsaur I, Mager R,
et al. Shikonin Inhibits Cell Growth of Sunitinib-Resistant Renal Cell Carcinoma by Activating the Necrosome Complex and Inhibiting the AKT/mTOR Signaling Pathway. Cancers. 2022; 14(5):1114.
https://doi.org/10.3390/cancers14051114
Chicago/Turabian Style
Markowitsch, Sascha D., Olesya Vakhrusheva, Patricia Schupp, Yasminn Akele, Jovana Kitanovic, Kimberly S. Slade, Thomas Efferth, Anita Thomas, Igor Tsaur, René Mager,
and et al. 2022. "Shikonin Inhibits Cell Growth of Sunitinib-Resistant Renal Cell Carcinoma by Activating the Necrosome Complex and Inhibiting the AKT/mTOR Signaling Pathway" Cancers 14, no. 5: 1114.
https://doi.org/10.3390/cancers14051114
APA Style
Markowitsch, S. D., Vakhrusheva, O., Schupp, P., Akele, Y., Kitanovic, J., Slade, K. S., Efferth, T., Thomas, A., Tsaur, I., Mager, R., Haferkamp, A., & Juengel, E.
(2022). Shikonin Inhibits Cell Growth of Sunitinib-Resistant Renal Cell Carcinoma by Activating the Necrosome Complex and Inhibiting the AKT/mTOR Signaling Pathway. Cancers, 14(5), 1114.
https://doi.org/10.3390/cancers14051114